本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Milestone Pharmaceuticals Inc.

0.8901
-0.0376-4.05%
成交量:120.43萬
成交額:110.32萬
市值:1.10億
市盈率:-1.32
高:0.9400
開:0.9398
低:0.8841
收:0.9277
52周最高:3.06
52周最低:0.8841
股本:1.24億
流通股本:1.06億
量比:0.65
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
淨資產收益率:-35522.62%
總資產收益率:-42.78%
市淨率:6.06
市盈率(LYR):-1.18

資料載入中...

2023/03/10

重要事件披露

8-K - Current report
2023/03/07

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]